Abstract:PURPOSE:To investigate whether rosiglitazone has a protective effect on retinal neural cells in diabetic rats, and to determine a possible anti-apoptotic mechanism.METHODS:Streptozotocin-induced diabetic rats and control animals were randomized evenly to receive rosiglitazone or not, effects were examined after 24 weeks. Retinal histology was examined and quantified using light microscopy; Apoptosis of retinal neural cells was determined by terminal dUTP nick-end labeling assay; Retinal ultrastructure was examined by transmission electron microscopy; Proteins levels of cleaved caspase-3, signal transduction and activators of transcription-3 (STAT3), phospho-STAT3 (p-STAT3), and suppressors of cytokine signaling 3 (SOCS3) in the retinal tissues were also determined by western blotting.RESULTS:Compared with the control group, the thickness of the overall retina, inner plexiform layer, inner nuclear layer reduced by 13.8%, 27.4% and 4.2%, respectively (p < 0.05) in the diabetic group after 24 weeks; The number of cells in the ganglion cell layer was also decreased by 18.6% (p < 0.05). There was apoptosis of retinal neurons in the diabetic rats. Diabetes also induced mitochondrial metamorphosis in ganglion cells and evident pyknosis in the outer nuclear layer. These effects were associated with increased levels of cleaved caspase-3, p-STAT3, and decreased levels of SOCS3. After treatment of rosiglitazone, the thickness of the retina and the number of cells in the ganglion cell layer were significantly greater than those in the diabetic group (p < 0.05). Rosiglitazone also attenuated the diabetic-induced apoptosis of retinal neurons and mitochondrial metamorphosis in ganglion cells. Consistent with these effects, rosiglitazone treatment also decreased cleaved caspase-3 and p-STAT3 expression and, at the same time, increased SOCS3 expression.CONCLUSIONS:Rosiglitazone attenuated diabetes-induced apoptosis in retinal neurons through activities that may involve inhibition of p-STAT3 by induction of SOCS3, which suggested that rosiglitazone might be used to prevent retinal neuronal damage in diabetes mellitus.

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

Rosiglitazone Attenuates Cell Apoptosis Through Antioxidative and Anti-Apoptotic Pathways in the Hippocampi of Spontaneously Hypertensive Rats.

Protective Effects of Rosiglitazone on Non-Alcoholic Steatohepatitis in Rats

[PPAR Gamma Agonist Rosiglitazone Alleviates Hypoxia/reoxygenation-Induced Oxidative Stress and Apoptosis in Rat Cardiac Myocytes].

Rosiglitazone Attenuates Renal Injury Caused By Hyperlipidemic Pancreatitis

Protective mechanism of rosiglitazone on renal injury of severe acute pancreatitis

Rosiglitazone Ameliorates Diabetic Nephropathy by Inhibiting Reactive Oxygen Species and Its Downstream-Signaling Pathways

Effects of rosiglitazone on expressions of peroxisome proliferator-activated receptor gamma and TGF-β1 in rats with adriamycin nephrosis

Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells

Protective Effects of Rosiglitazone on Retinal Neuronal Damage in Diabetic Rats

Rosiglitazone Attenuates the Severity of Sodium Taurocholate-induced Acute Pancreatitis and Pancreatitis-associated Lung Injury

Cardioprotective effects of acute rosiglitazone treatment

Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway

Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR γ/NLRP3 Signaling Pathway

Effect of peroxisome proliferator-activated receptor-γ ligand on acute necrotizing pancreatitis associated lung injury in rats

Rosiglitazone Inhibits High Glucose-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Through the PI3K/Akt/eNOS Pathway

Rosiglitazone Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Down-Regulating NF-κB-TNF-α Signaling Pathway in a PPARγ-dependent Manner.

Rosiglitazone Attenuates Myocardial Remodeling in Spontaneously Hypertensive Rats